Mindre potente UGT1A1 - hæmmere (f. eks. indinavir, saquinavir) kan også øge raltegravirs plasmakoncentration, men i mindre grad end atazanavir.
Less potent UGT1A1 inhibitors (e. g., indinavir, saquinavir) may also increase plasma levels of raltegravir, but to a lesser extent compared with atazanavir.